1. Banff 07 classification of renal allograft pathology: updates and future directions. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M (2008) Am J Transplant 8(4): 753-60
    › Primary publication · 18294345 (PubMed)
  2. PPAR-gamma agonist protects podocytes from injury. Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB (2007) Kidney Int 71(12): 1232-9
    › Primary publication · 17457378 (PubMed)
  3. Modulation of glomerulosclerosis. Ma LJ, Fogo AB (2007) Semin Immunopathol 29(4): 385-95
    › Primary publication · 17828397 (PubMed)
  4. Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency. Brown NJ, Bradford J, Wang Z, Lea W, Ma L, Ma J, Vaughan DE, Fogo AB (2007) Kidney Int 72(1): 72-81
    › Primary publication · 17429342 (PubMed)
  5. Mechanisms of progression of chronic kidney disease. Fogo AB (2007) Pediatr Nephrol 22(12): 2011-22
    › Primary publication · 17647026 (PubMed) · PMC2064942 (PubMed Central)
  6. Genetics of diabetic nephropathy: lessons from mice. Breyer MD, Tchekneva E, Qi Z, Takahashi T, Fogo AB, Zhao HJ, Harris RC (2007) Semin Nephrol 27(2): 237-47
    › Primary publication · 17418691 (PubMed)
  7. Examining diabetic nephropathy through the lens of mouse genetics. Breyer MD, Tchekneva E, Qi Z, Takahashi T, Fogo AB, Harris RC (2007) Curr Diab Rep 7(6): 459-66
    › Primary publication · 18255011 (PubMed)
  8. Effects of podocyte injury on glomerular development. Ma J, Rossini M, Yang HC, Zuo Y, Fogo AB, Ichikawa I (2007) Pediatr Res 62(4): 417-21
    › Primary publication · 17667850 (PubMed)
  9. Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy. Dwyer JP, Yates KM, Sumner EL, Stone WJ, Wang Y, Koury MJ, Fogo AB, Zent R (2007) Clin Nephrol 67(3): 176-81
    › Primary publication · 17390742 (PubMed)
  10. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. Tchekneva EE, Rinchik EM, Polosukhina D, Davis LS, Kadkina V, Mohamed Y, Dunn SR, Sharma K, Qi Z, Fogo AB, Breyer MD (2007) J Am Soc Nephrol 18(1): 103-12
    › Primary publication · 17151334 (PubMed)